-
★
Coronaimpfung: Myokarditis-Risiko bei jüngeren Männern nach der 2. Dosis erhöht
(Hinzugefügt: 07.10.2021 um 06:49 Uhr)
https://www.aerzteblatt.de/nachrichten/127936/Coronaimpfung-Myokarditis-Risiko-bei-juengeren-Maennern-nach-der-2-Dosis-erhoeht
-
★
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
(Hinzugefügt: 07.10.2021 um 06:42 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2110737
-
★
Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older
(Hinzugefügt: 05.10.2021 um 09:35 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2784800
-
★
SARS-CoV-2: Schutzwirkung von BNT162b2 lässt etwas schneller nach als bei mRNA-1273
(Hinzugefügt: 22.09.2021 um 10:31 Uhr)
https://www.aerzteblatt.de/nachrichten/127433/SARS-CoV-2-Schutzwirkung-von-BNT162b2-laesst-etwas-schneller-nach-als-bei-mRNA-1273
-
★
Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
(Hinzugefügt: 15.09.2021 um 14:43 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783685
-
★
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
(Hinzugefügt: 14.09.2021 um 07:30 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2110362
-
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
(Hinzugefügt: 19.11.2022 um 20:25 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2205667
-
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
(Hinzugefügt: 26.10.2022 um 14:16 Uhr)
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00244-9/fulltext
-
Limited induction of lung-resident memory T cell responses against SARS-CoV-2 by mRNA vaccination
(Hinzugefügt: 30.05.2022 um 14:17 Uhr)
https://www.medrxiv.org/content/10.1101/2022.05.25.22275300v1
-
Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database
(Hinzugefügt: 27.05.2022 um 07:36 Uhr)
https://www.mdpi.com/2076-393X/10/5/799/htm
-
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
(Hinzugefügt: 26.04.2022 um 13:38 Uhr)
https://www.medrxiv.org/content/10.1101/2022.04.15.22273914v1
-
Myocarditis Outcomes Following mRNA COVID-19 Vaccination
(Hinzugefügt: 03.04.2022 um 17:39 Uhr)
https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-02-04/04-COVID-Kracalic-508.pdf
-
Datenbankauswertung: Nebenwirkungen von COVID-19-mRNA-Impfstoffen sind leicht und vorübergehend
(Hinzugefügt: 11.03.2022 um 11:14 Uhr)
https://www.aerzteblatt.de/nachrichten/132377/Datenbankauswertung-Nebenwirkungen-von-COVID-19-mRNA-Impfstoffen-sind-leicht-und-voruebergehend
-
US-Studie: Myokarditisrate nach mRNA-Impfung auch bei Frauen erhöht
(Hinzugefügt: 17.02.2022 um 07:33 Uhr)
https://www.aerzteblatt.de/nachrichten/131263/US-Studie-Myokarditisrate-nach-mRNA-Impfung-auch-bei-Frauen-erhoeht
-
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
(Hinzugefügt: 17.02.2022 um 06:56 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00280-9/fulltext
-
Wie Sie eine Herzmuskelentzündung erkennen
(Hinzugefügt: 17.02.2022 um 06:29 Uhr)
https://www.t-online.de/gesundheit/krankheiten-symptome/id_90171996/corona-wie-sich-eine-herzmuskelentzuendung-erkennen-laesst.html
-
Sind Lipidnanopartikel bei der Pathogenese der mRNA-Impfstoff-assoziierten Myokarditis relevant?
(Hinzugefügt: 31.01.2022 um 15:37 Uhr)
https://www.aerzteblatt.de/nachrichten/131353/Sind-Lipidnanopartikel-bei-der-Pathogenese-der-mRNA-Impfstoff-assoziierten-Myokarditis-relevant
-
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
(Hinzugefügt: 29.12.2021 um 17:44 Uhr)
https://www.researchsquare.com/article/rs-1168453/v1
-
Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
(Hinzugefügt: 28.12.2021 um 14:38 Uhr)
https://www.sciencedirect.com/science/article/pii/S2589936821000839
-
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
(Hinzugefügt: 28.12.2021 um 14:35 Uhr)
https://www.nature.com/articles/s41569-021-00662-w
-
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium
(Hinzugefügt: 27.12.2021 um 16:45 Uhr)
https://www.medrxiv.org/content/10.1101/2021.12.23.21267853v1
-
mRNA vaccines: hope beneath the hype
(Hinzugefügt: 07.12.2021 um 07:18 Uhr)
https://www.bmj.com/content/375/bmj.n2744
-
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
(Hinzugefügt: 01.12.2021 um 18:11 Uhr)
https://www.science.org/doi/10.1126/scitranslmed.abm3302
-
Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination
(Hinzugefügt: 12.10.2021 um 11:33 Uhr)
https://www.nature.com/articles/s41586-021-04060-7
-
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans
(Hinzugefügt: 07.10.2021 um 06:52 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784769
-
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
(Hinzugefügt: 27.09.2021 um 09:54 Uhr)
https://www.medrxiv.org/content/10.1101/2021.09.16.21263686v1
-
The tangled history of mRNA vaccines
(Hinzugefügt: 24.09.2021 um 11:05 Uhr)
https://www.nature.com/articles/d41586-021-02483-w
-
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel
(Hinzugefügt: 23.09.2021 um 09:48 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2106599
-
Moderna-CEO Stéphane Bancel (49) über die neuste mRNA-Technik und den Kampf gegen Krebs «Die Lebenserwartung wird spürbar steigen»
(Hinzugefügt: 23.09.2021 um 09:47 Uhr)
https://www.blick.ch/wirtschaft/moderna-ceo-stephane-bancel-49-ueber-die-neuste-mrna-technik-die-lebenserwartung-wird-spuerbar-steigen-id16852999.html
-
Gritstone Announces Dosing of First Volunteer in Trial Evaluating Self-Amplifying mRNA as a COVID-19 Vaccine Booster and Immunogenicity Enhancer
(Hinzugefügt: 22.09.2021 um 10:40 Uhr)
https://ir.gritstonebio.com/news-releases/news-release-details/gritstone-announces-dosing-first-volunteer-trial-evaluating-self/
-
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
(Hinzugefügt: 22.09.2021 um 10:33 Uhr)
https://www.cell.com/immunity/fulltext/S1074-7613(21)00396-4#secsectitle0020
-
mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis
(Hinzugefügt: 19.09.2021 um 14:52 Uhr)
https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1
-
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
(Hinzugefügt: 15.09.2021 um 15:55 Uhr)
https://www.bmj.com/content/374/bmj.n1943
-
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
(Hinzugefügt: 15.09.2021 um 15:11 Uhr)
https://www.biorxiv.org/content/10.1101/2021.08.31.458247v1
-
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2
(Hinzugefügt: 15.09.2021 um 15:07 Uhr)
https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708
-
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
(Hinzugefügt: 15.09.2021 um 14:44 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2784015
-
Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink
(Hinzugefügt: 15.09.2021 um 14:44 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2784017
-
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
(Hinzugefügt: 15.09.2021 um 14:35 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2784015
-
Pfizer picked a COVID-19 vaccine dose far lower than Moderna's to minimize side effects, its top scientist says
(Hinzugefügt: 14.09.2021 um 07:22 Uhr)
https://www.businessinsider.com/pfizer-lower-dose-moderna-covid-19-vaccine-fewer-side-effects-2021-9
-
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
(Hinzugefügt: 28.08.2021 um 13:48 Uhr)
https://www.bmj.com/content/374/bmj.n1943
-
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
(Hinzugefügt: 28.08.2021 um 13:46 Uhr)
https://www.nature.com/articles/s41573-021-00283-5
-
mRNA Was Supposed To Stay Ahead Of Variants. Why Aren't We Using Its Full Potential?
(Hinzugefügt: 28.08.2021 um 13:42 Uhr)
https://www.wbur.org/news/2021/08/27/covid-vaccine-delta-variant
-
mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
(Hinzugefügt: 26.08.2021 um 04:33 Uhr)
https://www.biorxiv.org/content/10.1101/2021.08.23.457229v1
-
Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model
(Hinzugefügt: 24.08.2021 um 15:12 Uhr)
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927
-
Myocarditis and Pericarditis following COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
(Hinzugefügt: 14.08.2021 um 09:07 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349442/
-
A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination
(Hinzugefügt: 06.08.2021 um 10:48 Uhr)
https://www.medrxiv.org/content/10.1101/2021.08.01.21261297v1
-
Erst T-Zellen, dann Antikörper Wie mRNA-Impfungen im Körper wirken
(Hinzugefügt: 03.08.2021 um 10:18 Uhr)
https://www.n-tv.de/wissen/Wie-mRNA-Impfungen-im-Koerper-wirken-article22711004.html
-
Antibody Evolution after SARS-CoV-2 mRNA Vaccination
(Hinzugefügt: 03.08.2021 um 10:03 Uhr)
https://www.biorxiv.org/content/10.1101/2021.07.29.454333v1
-
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
(Hinzugefügt: 03.08.2021 um 10:00 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996517/
-
MYOKARDITIS UNTER mRNA-IMPFSTOFFEN: WARNHINWEISE JETZT AUCH IN EUROPA
(Hinzugefügt: 28.07.2021 um 12:32 Uhr)
https://www.arznei-telegramm.de/html/2021_07/2107510_01.html
-
Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection
(Hinzugefügt: 27.07.2021 um 19:24 Uhr)
https://www.medrxiv.org/content/10.1101/2021.07.25.21261093v1
-
Single cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine
(Hinzugefügt: 17.07.2021 um 13:14 Uhr)
https://www.biorxiv.org/content/10.1101/2021.07.14.452381v1
-
WHO und EMA: Myokarditis seltene Komplikation von mRNA-Impfstoffen
(Hinzugefügt: 13.07.2021 um 07:15 Uhr)
https://www.aerzteblatt.de/nachrichten/125475/WHO-und-EMA-Myokarditis-seltene-Komplikation-von-mRNA-Impfstoffen
-
EU regulator: mRNA coronavirus vaccines possibly linked to heart swelling
(Hinzugefügt: 13.07.2021 um 07:09 Uhr)
https://www.politico.eu/article/eu-regulator-mrna-coronavirus-vaccines-possibly-linked-to-heart-swelling/
-
COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines
(Hinzugefügt: 13.07.2021 um 07:02 Uhr)
https://www.who.int/news/item/09-07-2021-gacvs-guidance-myocarditis-pericarditis-covid-19-mrna-vaccines
-
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
(Hinzugefügt: 01.07.2021 um 08:41 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2107058
-
Myokarditis: US-Impfkommission sieht keine Gefährdung durch seltene Komplikation von mRNA-Vakzinen
(Hinzugefügt: 30.06.2021 um 15:21 Uhr)
https://www.aerzteblatt.de/nachrichten/124979/Myokarditis-US-Impfkommission-sieht-keine-Gefaehrdung-durch-seltene-Komplikation-von-mRNA-Vakzinen
-
FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID shots
(Hinzugefügt: 30.06.2021 um 15:10 Uhr)
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-adds-warning-about-rare-heart-inflammation-pfizer-moderna-covid-vaccines-2021-06-26/?utm_source=reddit.com
-
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
(Hinzugefügt: 30.06.2021 um 15:01 Uhr)
https://www.nature.com/articles/s41586-021-03738-2
-
Canadian study finds mRNA vaccines produce more COVID-19 antibodies than AstraZeneca
(Hinzugefügt: 23.06.2021 um 17:47 Uhr)
https://globalnews.ca/news/7972729/covid-antibody-study-canada-vaccine/
-
CureVac COVID vaccine let-down spotlights mRNA design challenges
(Hinzugefügt: 21.06.2021 um 13:19 Uhr)
https://www.nature.com/articles/d41586-021-01661-0
-
Differences in IgG antibody responses following BNT162b2 and mRNA-1273 Vaccines
(Hinzugefügt: 21.06.2021 um 13:16 Uhr)
https://www.biorxiv.org/content/10.1101/2021.06.18.449086v1
-
Australia's first locally made COVID-19 mRNA vaccine candidate is set for clinical trials
(Hinzugefügt: 21.06.2021 um 13:15 Uhr)
https://mobile.abc.net.au/news/2021-06-20/mrna-covid-19-vaccine-trials-in-australia-variant-booster/100229294
-
Sperm Parameters Before and After COVID-19 mRNA Vaccination
(Hinzugefügt: 20.06.2021 um 17:29 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2781360
-
pioneer behind mRNA: Kariko
(Hinzugefügt: 11.06.2021 um 06:34 Uhr)
https://www.nytimes.com/2021/06/10/podcasts/the-daily/mrna-vaccines-katalin-kariko.html
-
Corona-Impfstoff Curevac effizienter als Biontech und Moderna?
(Hinzugefügt: 09.06.2021 um 19:43 Uhr)
https://www.24hamburg.de/hamburg/corona-impfstoff-curevac-effizienter-als-biontech-und-moderna-zr-90791447.html
-
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD and S2
(Hinzugefügt: 09.06.2021 um 19:17 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(21)00706-6#.YL-kywF6ON0.twitter
-
Katalin Karikó
(Hinzugefügt: 06.06.2021 um 15:01 Uhr)
https://de.wikipedia.org/wiki/Katalin_Karik%C3%B3
-
Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines
(Hinzugefügt: 06.06.2021 um 14:39 Uhr)
https://www.medrxiv.org/content/10.1101/2021.06.01.21257987v2
-
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada
(Hinzugefügt: 31.05.2021 um 18:06 Uhr)
https://www.medrxiv.org/content/10.1101/2021.05.24.21257744v1
-
Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine
(Hinzugefügt: 27.05.2021 um 17:04 Uhr)
https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.3465
-
Low-dose single-shot COVID-19 mRNA vaccines lie ahead
(Hinzugefügt: 25.05.2021 um 14:07 Uhr)
https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(21)00255-0
-
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
(Hinzugefügt: 22.05.2021 um 17:08 Uhr)
https://www.cdc.gov/mmwr/volumes/70/wr/mm7020e2.htm
-
SARS-CoV-2 mRNA vaccines induce a greater array of spike-specific antibody isotypes with more potent complement binding capacity than natural infection
(Hinzugefügt: 20.05.2021 um 06:36 Uhr)
https://www.medrxiv.org/content/10.1101/2021.05.11.21256972v1
-
Rapid and stable mobilization of fully functional spike-specific CD8+ T cells preceding a mature humoral response after SARS-CoV-2 mRNA vaccination
(Hinzugefügt: 20.05.2021 um 06:35 Uhr)
https://www.researchsquare.com/article/rs-505193/v1
-
Blutungen und Krämpfe nach Corona-Impfung – Berichte über Veränderungen der Menstruation
(Hinzugefügt: 16.05.2021 um 10:05 Uhr)
https://www.fr.de/wissen/corona-coronavirus-impfung-impfstoff-menstruation-periode-blutungen-kraempfe-90479717.amp.html
-
Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial
(Hinzugefügt: 15.05.2021 um 10:11 Uhr)
https://www.680news.com/2021/05/13/canadian-vaccine-maker-mrna-pfizer-doug-ford-vaccinations-september-22/
-
4 Myths About COVID-19 mRNA Vaccines and Why They’re Wrong
(Hinzugefügt: 15.05.2021 um 10:09 Uhr)
https://roguescientist.co/4-myths-about-covid-19-mrna-vaccines-and-why-theyre-wrong/
-
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
(Hinzugefügt: 10.05.2021 um 06:06 Uhr)
https://www.mdpi.com/2076-393X/9/2/147/htm
-
Biontech und Moderna: EMA prüft Risiko von Blutgerinnseln
(Hinzugefügt: 08.05.2021 um 12:22 Uhr)
https://www.aerzteblatt.de/nachrichten/123705/Biontech-und-Moderna-EMA-prueft-Risiko-von-Blutgerinnseln
-
Nach Impfung mit Biontech EMA prüft Fälle von Herzmuskelentzündung
(Hinzugefügt: 05.05.2021 um 08:08 Uhr)
https://www.n-tv.de/panorama/EMA-prueft-Faelle-von-Herzmuskelentzuendung-article22523357.html
-
Association of Facial Paralysis With mRNA COVID-19 Vaccines
(Hinzugefügt: 30.04.2021 um 05:53 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2779389
-
Antibody response after COVID-19 mRNA vaccination in relation to age, sex, and side effects
(Hinzugefügt: 29.04.2021 um 07:22 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.19.21255714v1
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
(Hinzugefügt: 29.04.2021 um 07:11 Uhr)
https://www.cdc.gov/mmwr/volumes/70/wr/mm7018e1.htm
-
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
(Hinzugefügt: 25.04.2021 um 21:53 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051010/
-
Pernio after COVID-19 Vaccination
(Hinzugefügt: 25.04.2021 um 21:50 Uhr)
https://pubmed.ncbi.nlm.nih.gov/33893637/
-
Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
(Hinzugefügt: 25.04.2021 um 21:30 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/
-
BRIEF-EMA Says Increase In Vaccine Manufacturing Capacity, Supply For COVID-19 Vaccines From Biontech/Pfizer & Moderna
(Hinzugefügt: 24.04.2021 um 05:56 Uhr)
https://www.reuters.com/article/brief-ema-says-increase-in-vaccine-manuf-idUSFWN2MG0Q8
-
Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine
(Hinzugefügt: 16.04.2021 um 12:30 Uhr)
https://osf.io/a9jdq/
-
Central obesity, smoking habit and hypertension are associated with a blunted serological response to COVID-19 mRNA vaccine
(Hinzugefügt: 16.04.2021 um 12:21 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.13.21255402v1
-
The mRNA Vaccines Are Looking Better and Better
(Hinzugefügt: 15.04.2021 um 06:28 Uhr)
https://www.theatlantic.com/health/archive/2021/04/mrna-vaccines-johnson-blood-clots/618594/
-
Revolutionary mRNA vaccines made by Chinese firms will be ready to hit market by end of year, says industry chief
(Hinzugefügt: 10.04.2021 um 05:35 Uhr)
https://www.scmp.com/news/china/politics/article/3128998/revolutionary-mrna-vaccines-made-chinese-firms-will-be-ready
-
Kati Kariko Helped Shield the World From the Coronavirus
(Hinzugefügt: 09.04.2021 um 06:09 Uhr)
https://www.nytimes.com/2021/04/08/health/coronavirus-mrna-kariko.html
-
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
(Hinzugefügt: 08.04.2021 um 13:18 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.06.21254949v1
-
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
(Hinzugefügt: 08.04.2021 um 06:30 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.05.21254952v1
-
COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women
(Hinzugefügt: 06.04.2021 um 06:53 Uhr)
https://www.biorxiv.org/content/10.1101/2021.04.04.438404v1
-
CDC Real-World Study Confirms Protective Benefits of mRNA COVID-19 Vaccines
(Hinzugefügt: 02.04.2021 um 20:01 Uhr)
https://www.cdc.gov/media/releases/2021/p0329-COVID-19-Vaccines.html
-
Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
(Hinzugefügt: 02.04.2021 um 04:32 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2102051
-
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2
(Hinzugefügt: 29.03.2021 um 18:33 Uhr)
https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e3.htm
-
COVID-19: mRNA-Impfung auch bei chronischen Entzündungserkrankungen sicher und wirksam
(Hinzugefügt: 26.03.2021 um 07:59 Uhr)
https://www.precisionmedicine.de/de/detailansicht/news/covid-19-mrna-impfung-auch-bei-chronischen-entzuendungserkrankungen-sicher-und-wirksam
-
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
(Hinzugefügt: 24.03.2021 um 09:10 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2101927
-
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center
(Hinzugefügt: 24.03.2021 um 09:09 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2102153
-
Nebenwirkungen der Covid-19 Impfungen in der Schweiz – Update
(Hinzugefügt: 17.03.2021 um 02:09 Uhr)
https://www.swissmedic.ch/swissmedic/de/home/news/coronavirus-covid-19/nebenwirkungen-covid-19-impfungen-ch.html
-
The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
(Hinzugefügt: 15.03.2021 um 19:27 Uhr)
https://www.biorxiv.org/content/10.1101/2021.03.04.430128v1
-
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
(Hinzugefügt: 14.03.2021 um 21:37 Uhr)
https://www.biorxiv.org/content/10.1101/2021.01.15.426911v2
-
Israel plans to start injecting 12-15 year olds with Pfizer's mRNA shot - before the FDA approves it
(Hinzugefügt: 14.03.2021 um 06:06 Uhr)
https://www.allisrael.com/will-israel-preempt-fda-approval-and-start-injecting-12-15-year-olds-with-mrna-shot-most-likely
-
Coronaimpfung: Es darf keinen Engpass bei Spritzen und Kanülen geben
(Hinzugefügt: 13.03.2021 um 08:02 Uhr)
https://www.aerzteblatt.de/nachrichten/121978/Coronaimpfung-Es-darf-keinen-Engpass-bei-Spritzen-und-Kanuelen-geben
-
AUFKLÄRUNGSMERKBLATT Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) – mit mRNA-Impfstoffen –
(Hinzugefügt: 12.03.2021 um 06:03 Uhr)
https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Downloads-COVID-19/Aufklaerungsbogen-de.pdf?__blob=publicationFile
-
Nebenwirkungen der Covid-19 Impfungen in der Schweiz – Update
(Hinzugefügt: 11.03.2021 um 14:39 Uhr)
https://www.swissmedic.ch/swissmedic/de/home/news/coronavirus-covid-19/nebenwirkungen-covid-19-impfungen-ch-update.html
-
Acute Allergic Reactions to mRNA COVID-19 Vaccines
(Hinzugefügt: 11.03.2021 um 08:16 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2777417
-
SARS-CoV-2 mRNA vaccines induce a robust germinal centre reaction in humans
(Hinzugefügt: 10.03.2021 um 20:17 Uhr)
https://www.researchsquare.com/article/rs-310773/v1
-
„COVID-ARM“ EINE WOCHE NACH IMPFUNG ... irritierende, aber harmlose verzögerte Lokalreaktion nach mRNA-Impfstoffen
(Hinzugefügt: 10.03.2021 um 08:34 Uhr)
https://www.arznei-telegramm.de/html/2021_03/2103502_01.html
-
RKI: COVID-19-Impfung mRNA-basierte Impfung
(Hinzugefügt: 05.03.2021 um 06:56 Uhr)
https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Faktenblaetter/COVID-19.pdf?__blob=publicationFile
-
CPI receives £5million investment from UK Government to develop ‘library’ of mRNA vaccines to help fight new COVID-19 variants
(Hinzugefügt: 04.03.2021 um 15:24 Uhr)
https://www.uk-cpi.com/news/cpi-receives-5million-investment-from-uk-government-to-develop-library-of-mrna-vaccines-to-help-fight-new-covid-19-variants
-
How to Administer RNA – And How to Do It Again
(Hinzugefügt: 04.03.2021 um 08:19 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/03/03/how-to-administer-rna-and-how-to-do-it-again
-
Kurz vor Ende der Amtszeit Trump ließ sich heimlich gegen Corona impfen
(Hinzugefügt: 02.03.2021 um 06:43 Uhr)
https://www.spiegel.de/politik/ausland/donald-trump-liess-sich-bereits-im-januar-still-und-heimlich-gegen-corona-impfen-a-7f146980-818b-4792-83f7-73e2d42b1e11?sara_ecid=soci_upd_KsBF0AFjflf0DZCxpPYDCQgO1dEMph
-
U.S. administers 72.8 million doses of COVID-19 vaccines: CDC
(Hinzugefügt: 28.02.2021 um 07:37 Uhr)
https://www.reuters.com/article/us-health-coronavirus-usa-cdc-idUSKCN2AR0M3
-
Bell's palsy and SARS-CoV-2 vaccines
(Hinzugefügt: 26.02.2021 um 03:14 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00076-1/fulltext
-
More on mRNA Vaccine Manufacturing
(Hinzugefügt: 23.02.2021 um 08:55 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/02/22/more-on-mrna-vaccine-manufacturing
-
New Data Boost Calls for Single COVID-19 Vaccine Dose
(Hinzugefügt: 19.02.2021 um 10:18 Uhr)
https://www.medscape.com/viewarticle/946102
-
What does 95% COVID-19 vaccine efficacy really mean?
(Hinzugefügt: 18.02.2021 um 08:05 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00075-X/fulltext
-
How Our Brutal Science System Almost Cost Us A Pioneer Of mRNA Vaccines
(Hinzugefügt: 15.02.2021 um 08:49 Uhr)
https://www.wbur.org/commonhealth/2021/02/12/brutal-science-system-mrna-pioneer
-
Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines—Much ado about nothing?
(Hinzugefügt: 14.02.2021 um 10:26 Uhr)
https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.14763
-
69 million doses of COVID-19 vaccines delivered, 48.4 million administered: U.S. CDC
(Hinzugefügt: 13.02.2021 um 13:22 Uhr)
https://www.reuters.com/article/us-health-coronavirus-usa-cdc-idUSKBN2AC2AS
-
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
(Hinzugefügt: 13.02.2021 um 13:20 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2776557?guestAccessKey=02bace70-31a0-4d1c-bf78-91f88c9cbc6c&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=021221
-
Rare Blood Disorder Could Be Linked To Covid Vaccine
(Hinzugefügt: 11.02.2021 um 12:39 Uhr)
https://khn.org/morning-breakout/rare-blood-disorder-could-be-linked-to-covid-vaccine/
-
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
(Hinzugefügt: 07.02.2021 um 15:53 Uhr)
https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html
-
Warum die Verhandlungen so lange stockten
(Hinzugefügt: 06.02.2021 um 09:32 Uhr)
https://www.tagesschau.de/investigativ/ndr-wdr/corona-pandemie-eu-impfstoffe-101.html
-
CDC Updates Contraindications to COVID-19 Vaccination
(Hinzugefügt: 31.01.2021 um 18:47 Uhr)
https://www.medpagetoday.com/infectiousdisease/covid19/90501
-
69 Todesfälle nach Corona-Impfungen überprüft: Paul-Ehrlich-Institut gibt Entwarnung
(Hinzugefügt: 30.01.2021 um 11:32 Uhr)
https://www.rtl.de/cms/69-todesfaelle-nach-corona-impfungen-ueberprueft-paul-ehrlich-institut-gibt-entwarnung-4694103.html
-
CDC quietly changes Covid vaccine guidance to OK mixing Pfizer and Moderna shots in ‘exceptional situations’
(Hinzugefügt: 22.01.2021 um 21:52 Uhr)
https://www.cnbc.com/2021/01/22/cdc-changes-covid-vaccine-guidance-to-ok-mixing-pfizer-and-moderna-shots-in-exceptional-si.html
-
39.9 million doses of COVID-19 vaccines distributed, 19.1 million administered: U.S. CDC
(Hinzugefügt: 22.01.2021 um 21:49 Uhr)
https://www.reuters.com/article/us-health-coronavirus-usa-cdc-idUSKBN29R2JR
-
mRNA Vaccines: What Happens
(Hinzugefügt: 22.01.2021 um 08:57 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/01/21/mrna-vaccines-what-happens
-
SARS-CoV-2: Laborexperimente deuten auf verminderte Schutzwirkung gegen neue Varianten hin
(Hinzugefügt: 21.01.2021 um 19:23 Uhr)
https://www.aerzteblatt.de/nachrichten/120379/SARS-CoV-2-Laborexperimente-deuten-auf-verminderte-Schutzwirkung-gegen-neue-Varianten-hin
-
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
(Hinzugefügt: 20.01.2021 um 08:47 Uhr)
https://www.biorxiv.org/content/10.1101/2021.01.15.426911v1
-
Exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 vaccines
(Hinzugefügt: 20.01.2021 um 08:29 Uhr)
https://blog.jonasneubert.com/2021/01/10/exploring-the-supply-chain-of-the-pfizer-biontech-and-moderna-covid-19-vaccines/
-
Vancouver nanomedicine firm using new technology to develop COVID-19 vaccine
(Hinzugefügt: 18.01.2021 um 07:17 Uhr)
https://vancouversun.com/news/vancouver-nanomedicine-firm-using-new-technology-to-develop-covid-19-vaccine
-
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
(Hinzugefügt: 14.01.2021 um 05:02 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00085-4/fulltext
-
RNA vaccines and how they work
(Hinzugefügt: 13.01.2021 um 19:34 Uhr)
https://www.reddit.com/r/Coronavirus/comments/kwlqmb/rna_vaccines_and_how_they_work/?utm_source=share&utm_medium=web2x&context=3
-
How COVID unlocked the power of RNA vaccines
(Hinzugefügt: 13.01.2021 um 08:28 Uhr)
https://www.nature.com/articles/d41586-021-00019-w
-
Future Considerations for the mRNA–Lipid Nanoparticle Vaccine Platform
(Hinzugefügt: 13.01.2021 um 08:17 Uhr)
https://www.preprints.org/manuscript/202012.0493/v2
-
Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
(Hinzugefügt: 12.01.2021 um 20:24 Uhr)
https://www.bmj.com/content/371/bmj.m4037/rr-19
-
RNA Vaccines And Their Lipids
(Hinzugefügt: 12.01.2021 um 07:59 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/01/11/rna-vaccines-and-their-lipids
-
SARS-CoV-2: EMA macht Weg frei für zweiten mRNA-Impfstoff
(Hinzugefügt: 07.01.2021 um 05:23 Uhr)
https://www.aerzteblatt.de/nachrichten/119888/SARS-CoV-2-EMA-macht-Weg-frei-fuer-zweiten-mRNA-Impfstoff
-
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data
(Hinzugefügt: 07.01.2021 um 04:55 Uhr)
https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/
-
mRNA-Impfstoffe Biontechs und Modernas Impfstoffe im Vergleich
(Hinzugefügt: 05.01.2021 um 07:59 Uhr)
https://www.pharmazeutische-zeitung.de/biontechs-und-modernas-impfstoffe-im-vergleich-122791/
-
How mRNA went from a scientific backwater to a pandemic crusher
(Hinzugefügt: 03.01.2021 um 19:49 Uhr)
https://www.wired.co.uk/article/mrna-coronavirus-vaccine-pfizer-biontech
-
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Approach
(Hinzugefügt: 01.01.2021 um 10:53 Uhr)
https://www.jaci-inpractice.org/article/S2213-2198(20)31411-2/abstract
-
Maintaining Safety with SARS-CoV-2 Vaccines
(Hinzugefügt: 31.12.2020 um 11:39 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMra2035343
-
Want to Know More About mRNA Before Your COVID Jab?
(Hinzugefügt: 18.12.2020 um 21:22 Uhr)
https://www.medpagetoday.com/infectiousdisease/covid19/89998
-
Fever, aches from Pfizer, Moderna jabs aren’t dangerous but may be intense for some
(Hinzugefügt: 18.12.2020 um 21:17 Uhr)
https://www.sciencemag.org/news/2020/11/fever-aches-pfizer-moderna-jabs-aren-t-dangerous-may-be-intense-some
-
Wikipedia: RNA vaccine
(Hinzugefügt: 18.12.2020 um 21:13 Uhr)
https://en.wikipedia.org/wiki/RNA_vaccine#cite_note-NAT1-5
-
mRNA vaccines — a new era in vaccinology
(Hinzugefügt: 18.12.2020 um 21:12 Uhr)
https://www.nature.com/articles/nrd.2017.243